TOPD Phenotype versus COPD: Pulmonary Function Spectrum Beyond the Limits of Spirometry
B Debbarma, A Srivastava, S Dixit, R Garg… - The Journal of …, 2024 - journals.lww.com
Aims: To compare the lung functions of TOPD phenotype patients and COPD patients other
than TOPD phenotype. Settings and design: Retro-prospective cohort study. Introduction …
than TOPD phenotype. Settings and design: Retro-prospective cohort study. Introduction …
The heterogeneity in COPD phenotypes
N Tanabe, CK Rhee, HY Park, M Suzuki - Frontiers in Medicine, 2022 - frontiersin.org
Chronic obstructive pulmonary disease (COPD) is diagnosed simply based on the presence
of not fully reversible airflow limitation on post-bronchodilator spirometry. However, there are …
of not fully reversible airflow limitation on post-bronchodilator spirometry. However, there are …
Progress in diagnosis and treatment in tuberculosis patients associated chronic obstructive pulmonary disease
XU Wei, WU Li-juan - Journal of Tuberculosis and Lung Disease, 2017 - jtbld.cn
The tuberculosis associated COPD (TOPD)() as a common chronic airway inflammation is
mostly found in elderly patients. TOPD may be prevented and treated in early stage, but in …
mostly found in elderly patients. TOPD may be prevented and treated in early stage, but in …
B13 ANY TIME AT ALL: DISEASE PROGRESSION AND EMERGING PHENOTYPES IN COPD: Predictors Of Lung Function Decline In Smokers In COPDgene Phase …
Methods We analyzed data from the COPDGene cohort which includes current and former
smokers (age 45-80 years) followed for change in post-bronchodilator FEV1 over five years …
smokers (age 45-80 years) followed for change in post-bronchodilator FEV1 over five years …
[HTML][HTML] COPDGene® 2019: redefining the diagnosis of chronic obstructive pulmonary disease
Background: Chronic obstructive pulmonary disease (COPD) remains a major cause of
morbidity and mortality. Present-day diagnostic criteria are largely based solely on …
morbidity and mortality. Present-day diagnostic criteria are largely based solely on …
COPD and biomarkers: the search goes on
GM Turino - Thorax, 2008 - thorax.bmj.com
1. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur
Respir J 2005; 26: 948–68. 2. Celli BR, MacNee W. Standards for the diagnosis and …
Respir J 2005; 26: 948–68. 2. Celli BR, MacNee W. Standards for the diagnosis and …
[HTML][HTML] Clinical and molecular markers in COPD
I Gonçalves, MJ Guimarães, M Van Zeller, F Menezes… - Pulmonology, 2018 - Elsevier
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease,
and there is a clinical need for validated markers and biomarkers that can contribute to the …
and there is a clinical need for validated markers and biomarkers that can contribute to the …
Factors Describing Chronic Obstructive Pulmonary Disease Predict All-Cause Mortality In Smokers
BACKGROUND Pulmonary Function Testing (PFT) is currently used to diagnose and risk
stratify Chronic Obstructive Pulmonary Disease (COPD), and CT imaging can be used in …
stratify Chronic Obstructive Pulmonary Disease (COPD), and CT imaging can be used in …
A unique spirometric phenotype in COPD
JM Bon, JL Weissfeld, FC Sciurba - American Journal of Respiratory …, 2008 - atsjournals.org
In the executive summary of the 2006 update of the Global Initiative for Chronic Obstructive
Lung Disease (GOLD) guidelines (1), the authors state that it is difficult to differentiate …
Lung Disease (GOLD) guidelines (1), the authors state that it is difficult to differentiate …
[HTML][HTML] Subtypes of COPD have unique distributions and differential risk of mortality
Background: Previous attempts to explore the heterogeneity of chronic obstructive
pulmonary disease (COPD) clustered individual patients using clinical, demographic, and …
pulmonary disease (COPD) clustered individual patients using clinical, demographic, and …